table of content
1 Introduction to Research & Analysis Reports
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Overall Market Size
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2021 VS 2028
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales: 2017-2028
3 Company Landscape
3.1 Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.2 Top Global Non-steroidal Anti-inflammatory Drugs (NSAID) Companies Ranked by Revenue
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies
3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.8.1 List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Markets, 2021 & 2028
4.1.2 Salicylates
4.1.3 Propionic acid derivatives
4.1.4 Acetic acid derivatives
4.1.5 Enolic acid (Oxicam) derivatives
4.1.6 Anthranilic acid derivatives (Fenamates)
4.1.7 Selective COX-2 inhibitors (Coxibs)
4.1.8 Sulfonanilides
4.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
4.2.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
4.2.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
4.2.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
4.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
4.3.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
4.3.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
4.3.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
4.4 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2021 & 2028
5.1.2 Human
5.1.3 Animals
5.1.4 Others
5.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
5.2.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
5.2.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
5.2.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
5.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
5.3.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
5.3.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
5.3.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
5.4 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2021 & 2028
6.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
6.2.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
6.2.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
6.2.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
6.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
6.3.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
6.3.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
6.3.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.4.2 By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.4.3 US Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.4.4 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.4.5 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.5.2 By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.5.3 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.4 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.5 U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.6 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.7 Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.8 Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.9 Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.6.2 By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.6.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.5 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.6 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.7 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.7.2 By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.7.3 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.7.4 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.8.3 Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8.4 Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8.5 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8.6 UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Key News
7.2 Ecotrin
7.2.1 Ecotrin Corporate Summary
7.2.2 Ecotrin Business Overview
7.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.2.5 Ecotrin Key News
7.3 Generic
7.3.1 Generic Corporate Summary
7.3.2 Generic Business Overview
7.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.3.5 Generic Key News
7.4 St. Joseph
7.4.1 St. Joseph Corporate Summary
7.4.2 St. Joseph Business Overview
7.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.4.5 St. Joseph Key News
7.5 Elanco
7.5.1 Elanco Corporate Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.5.5 Elanco Key News
7.6 Zoetis
7.6.1 Zoetis Corporate Summary
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.6.5 Zoetis Key News
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Corporate Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.7.5 Boehringer Ingelheim Key News
7.8 Merial
7.8.1 Merial Corporate Summary
7.8.2 Merial Business Overview
7.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.8.5 Merial Key News
7.9 Merck Animal Health
7.9.1 Merck Animal Health Corporate Summary
7.9.2 Merck Animal Health Business Overview
7.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.9.5 Merck Animal Health Key News
8 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, Analysis
8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, 2017-2028
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-steroidal Anti-inflammatory Drugs (NSAID) Supply Chain Analysis
10.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Upstream Market
10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
